Paramount plans November layoffs in $2 billion cost-cutting move - NYP
Ludmila Smolyansky, a member of the 10% owner group at Lifeway Foods, Inc. (NASDAQ:LWAY), a $330.7 million market cap company with a GREAT financial health rating according to InvestingPro, recently sold 29,726 shares of the company's common stock. The transactions, which took place between January 15 and January 17, 2025, were executed at prices ranging from $22.55 to $22.67 per share, totaling $671,675. The sale comes after the stock's impressive 71.8% surge over the past six months, with the company maintaining strong fundamentals including a healthy balance sheet with more cash than debt.
Following these sales, Smolyansky holds 965,823 shares indirectly through the Ludmila Smolyansky Trust. Additionally, she maintains interests in other entities, including The Ludmila and Edward Smolyansky Family Foundation and The Smolyansky Family Foundation, which collectively hold further shares. The transactions were reported in a Form 4 filing with the Securities and Exchange Commission. For deeper insights into LWAY's valuation and 10+ additional ProTips, visit InvestingPro, where you'll find comprehensive analysis and the exclusive Pro Research Report.
In other recent news, Lifeway Foods, a well-known supplier of kefir and fermented probiotic products, has rejected an acquisition proposal from Danone (EPA:DANO) North America PBC, maintaining that the offer significantly undervalues the company. This decision comes after Lifeway's impressive track record of 21 consecutive quarters of growth, with revenues rising from $94 million in 2019 to an anticipated $185.0 million to $186.5 million in 2024. The company's robust performance has also been highlighted by a 12.7% increase in net sales for the third quarter of 2024, reaching $46.1 million, largely attributed to its flagship drinkable kefir product.
In addition to the financial growth, Lifeway Foods has reported a year-to-date sales increase of 22% for its kefir product and an improvement in gross profit margins to 25.7% for the quarter. These recent developments underline Lifeway's commitment to delivering high-quality, nutritious products and its continued growth momentum.
The company has also outlined expansion plans that include new product introductions and increased distribution in international markets. Lifeway's rejection of Danone's proposal and its focus on expansion underscore the company's confidence in its standalone business plan. The next update on the company's performance will be provided during the year-end call.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.